Aktywność biologiczna izoflawonoidów i ich znaczenie terapeutyczne i kosmetyczne

1. Kraszewska O, Nynca A, Kamińska B i wsp. Fitoestrogeny. I. Występowanie, metabolizm i znaczenie biologiczne u samic. Post Biol Kom 2007; 34:189-205. 2. Kohlmünzer S. Farmakognozja. PZWL, Warszawa, 2000. 3. Malińska D, Kiersztan A. Flawonoidy - charakterystyka i znaczenie w terapii. Post Bioch 2004; 50:182-96. 4. Czerpak R, Jabłońska A. Zastosowanie cytokinin i izoflawonoidów w kosmetyce i terapii (II). Med Estet i Przeciwstarz 2005; 4:121-9. 5. Grynkiewicz G, Gadzikowska M. Fitoestrogeny jako selektywne modulatory aktywności receptorów estrogenowych. Post Fitoter 2003; 4:10-4. 6. Polkowski K, Mazurek AP. Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 2000; 57:135-55. 7. Jha HC, Recklinghausen G, Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem Pharmacol 1985; 34:1367-9. 8. Mitchell JH, Gardner PT, McPhail DB i wsp. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 1998; 360:142-8. 9. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Therap 2001; 90:157-77. 10. Breinholt U, Hossaini A, Svendsen GW i wsp. Estrogenic activity of flavonoids im mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem Toxicol 2000; 38:555-64. 11. Yeung DKY, Leung WS, Xu YC i wsp. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Europ J Pharmacol 2006; 552:105-11. 12. Miksicek RJ. Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exper Biol Med 1995; 208:44-50. 13. Tkaczyk M, Kalita K. Receptor estrogenowy - budowa, regulacja i funkcja. Post Biochem 2001; 47:72-78. 14. Adlercreutz H. Epidemiology of phytoestrogens. Baill Clin Endocrinol Metabol 1998; 12(4):605-23. 15. Czerpak R, Piotrowska A, Dobrzyń P i wsp. The effect of biochanin A on the chlorophylls and carotenoids content in the alga Chlorella vulgaris Beijerinck. Acta Physiol Plant 2003; 25:271-8. 16. Okura A, Arakawa H, Oka H i wsp. Effect of genistein on topoisomerase activity and on the growth of Ha-ras-transformed NIH3T3 cells. Biochem Biophys Res Commun 1988; 157:183-9. 17. Dixon RA, Ferreira D. Genistein. Phytochemistry 2002; 60:205-11. 18. Anderson JB, Anthony M, Messina M i wsp. Effect of phyto-oestrogens on tissue. Nutr Res Rev 1999; 12:75-116. 19. Asres K, Seyoum A, Veeresham C i wsp. Naturally derived anti-HIV agent. Phytother Res 2005; 19:557-81. 20. Noszczyk M. Wpływ estrogenów i fitoestrogenów na procesy związane ze starzeniem się skóry. Dermatol Estet 1999; 1:222-6. 21. Zhou HB, Chen JJ, Wang WX i wsp. Apoptosis of human primary gastric carcinoma cells induced by genistein. World J Gastroenterol 2004; 10(12):1822-5. 22. Wei H, Bowen R, Cai Q i wsp. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exper Biol Med 1995; 208:124-30. 23. Watanabe T, Kondo K, Oishi M. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res 1991; 51:764-8. 24. Wietrzyk J. Wpływ izoflawonoidów na aktywność przeciwnowotworową witaminy D. Post Hig Med Dośw 2007; 61:253-60. 25. Merz-Demlow BE, Duncan AM, Wangen KE i wsp. Soy isoflavones improve plasma lipids in normocholesterolemic premenopausal women. Am J Clin Nutr 2000; 71:1462-9. 26. Yanagihara K, Ito A, Toge T i wsp. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993; 53:5815-21. 27. Uckun FM, Evans WE, Forsyth CJ i wsp. Biotherapy of -cell precursor leukemia by targeting genistein to CD 19-associated tyrosine kinases. Science 1995; 267:886-91. 28. Wocławek-Potocka I, Acosta TJ, Korzekwa A i wsp. Phytoestrogens modulate prostaglandin production in bovine endometrium: cell type specificity and intracellular mechanisms. Exp Biol Med 2005; 230:326-33. 29. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 1998; 356:133-41. 30. Dave B, Eason RR, Till SR i wsp. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 2005; 26:1793-803. 31. Haddad NG, Fuqua JS. Phytoestrogens: effects on the reproductive system. Endocrinologist 2001; 11:498-505. 32. Kim EJ, Shin HK, Park JH. Genistein inhibits insulin-like growth factor - I receptor signaling in HAT-29 human colon cancer cells: a possible mechanism of growth inhibitory effect of genistein. J Med Food 2005; 8:431-8. 33. Deluca D, Krazeisen A, Breitling R i wsp. Inhibition of 17-b-hydroxysteroid dehydrogenases by phytoestrogens: comparison with other steroid metabolizing enzymes. J Steroid Biochem Mol Biol 2005; 93:285-92. 34. Dusza L, Ciereszko R, Skarzyński DJ i wsp. Mechanism of phytoestrogen action in reproductive processes of mammals and birds. Reprod Biol (suppl) 2006; 6:151-74. 35. Lee KH, Choi EM. Biochanin A stimulates osteoblastic differentiation and inhibits hydrogen peroxide induced production of inflammatory mediators in MC3T3-E1 cells. Biol Pharm Bull 2005; 28:1948-53. 36. Middleton JE, Kandaswami C, Theoharides TC. The effect of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000; 52:673-751. 37. Magec PJ, Rowland JR. Phyto-estrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Brit J Nutr 2004; 91:513-31. 38. Urbaniak B, Marcisz C. Wpływ soi i izoflawonów sojowych na tarczycę. Post Fitoter 2006; 7(2):83-9. 39. Grzenkowicz J, Wojtkowiak D, Podhajska AJ. Zmiana czynnościowa komórek skóry w odpowiedzi na stan zapalny. Pol J Cosmetol 2002; 3:182-92. 40. Branca F. Dietary phyto-oestrogens and bone health. Proc Nutr Soc 2003; 62:877-87. 41. Setchell KDR. Fitoestrogeny - biochemia, fizjologia oraz wpływ izoflawonów sojowych na zdrowie człowieka (cz. 1). Dermatol Estet 2001; 2:88-94. 42. Setchell KDR. Fitoestrogeny - biochemia, fizjologia oraz wpływ izoflawonów sojowych na zdrowie człowieka (cz. 2). Dermatol Estet 2001; 3:130-41. 43. Lutowski J. Fitoestrogeny w miejsce hormonów syntetycznych. Post Fitoter 2001; 2:9-11. 44. Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother Res 2003; 17:845-69. 45. Wang W, Liu LQ, Higuchi CM i wsp. Induction of NADPH: quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem Pharmacol 1998; 56:189-95. 46. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002; 3:364-73. 47. Davis JN, Singh B, Bhuiyah M i wsp. Genistein-induced upregulation of p21, downregulation of cyclin B and induction of apoptosis in prostate cancer cells. Nutr Cancer 1998; 32:123-31. 48. Akiyama T, Ishida J, Nakagawa S i wsp. Genistein a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262:5592-95. 49. Dean NM, Kanemitsu M, Boynton AL. Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 1OT1/2 fibroblasts and rat liver T51B cells. Biochem Biophys Res Commun 1989; 165:705-801. 50. Liu XJ, Yang L, Mao YQ i wsp. Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells. World J Gastroenterol 2002; 8:739-45. 51. Fotsis T, Pepper M, Adlercreutz H i wsp. Genistein a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993; 90:2690-94. 52. Zhang R, Li V, Wang W. Enhancement of immune function in mice fed high doses of soy daidzein. Nutr Cancer 1997; 29:24-8. 53. Sato M, Tanaka H, Fujiwara S i wsp. Antibacterial property of isoflavonoids isolated from Erythrina variegata against cariogenic oral bacteria. Phytomedicine 2002; 9:427-33. 54. Mielczarek C, Brzezińska E. Flawonoidy w kosmetyce i kosmetologii, cz. 1. Właściwości biologiczne flawonoidów. Pol J Cosmetol 2000; 1(1):11-21. 55. Farhan H, Wähälä K, Adlercreutz H i wsp. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr 2002; 777:261-68. 56. Mielczarek C, Brzezińska E. Flawonoidy w kosmetyce i kosmetologii, cz. 3. Praktyczne zastosowanie surowców flawonoidowych w kosmetyce. Pol J Cosmetol 2000; 1(3):156-63. 57. Kuczyński S. Hormony w kosmetykach. Beauty Forum 2003; 9:16-19.